US Broker Ratings

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 142.67% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) is a prominent player in the biotechnology sector, specializing in innovative treatments for severe endocrinologic, oncologic, metabolic, and neurologic disorders. With a market capitalization of..

Tempus AI, Inc. (TEM) Stock Analysis: A 32.66% Potential Upside Amidst Robust Revenue Growth

Tempus AI, Inc. (TEM), a pioneering healthcare technology company, has captured the attention of investors with its substantial market cap of $11.79 billion and a remarkable revenue growth rate of..

Bristol-Myers Squibb Company (BMY) Stock Analysis: Understanding the Potential with a 4.51% Dividend Yield and Robust Free Cash Flow

Investors eyeing the healthcare sector would do well to consider Bristol-Myers Squibb Company (NYSE: BMY), a formidable player in the biopharmaceutical space with a market capitalization of $113.72 billion. With..

Solventum Corporation (SOLV) Stock Analysis: A Healthcare Leader with Promising Upside and Strong Return on Equity

Solventum Corporation (NASDAQ: SOLV) stands out as a formidable player in the healthcare sector, specializing in medical instruments and supplies. With a robust market capitalization of $14.94 billion, this Maplewood,..

Legend Biotech Corporation (LEGN) Stock Report: Analysts Predict 204% Upside with Revolutionary CAR-T Therapies

For investors eyeing the healthcare sector, Legend Biotech Corporation (NASDAQ: LEGN) stands out as a compelling opportunity. With a market capitalization of $4.36 billion, the company is making waves in..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 9.90% Potential Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector as a dynamic player in the drug manufacturing industry, specifically within the specialty and generic drug space. With a..

DaVita Inc. (DVA) Stock Analysis: Exploring the 28% Potential Upside in Healthcare’s Dialysis Leader

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services for patients with chronic kidney failure. Based in Denver, Colorado, DaVita’s extensive network..

Globus Medical, Inc. (GMED) Stock Analysis: A Strong Buy on Impressive 12.63% Potential Upside

Globus Medical, Inc. (NYSE: GMED), a leading player in the medical devices industry, is capturing investor attention with a robust market cap of $12.76 billion and a promising potential upside..

Moderna, Inc. (MRNA) Stock Analysis: Insights into its 6.71% Potential Upside Despite Revenue Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts,..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 9.81% Upside in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Venlo, Netherlands, Qiagen is known for offering a comprehensive..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Healthcare Distribution with a $9.42 Billion Market Cap

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare distribution sector, offering a diverse range of products and services that cater to dental and medical practitioners..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 22.84% Potential Upside in Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV) is capturing the attention of investors with its ambitious efforts in the biotechnology sector, despite a challenging financial landscape. Based in London, this clinical-stage biopharmaceutical..

Option Care Health, Inc. (OPCH) Stock Analysis: A 16% Upside Potential in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the medical care facilities industry, is making waves with its robust growth potential and strategic positioning within the healthcare sector...

AptarGroup, Inc. (ATR) Stock Analysis: Eyeing a 28.5% Upside with Strong Analyst Support

For investors seeking a compelling opportunity in the healthcare sector, AptarGroup, Inc. (NYSE: ATR) presents a noteworthy case. Known for its innovative solutions in drug delivery and consumer product dispensing,..

Agilent Technologies, Inc. (A) Investor Outlook: Potential 13.51% Upside Amid Robust Growth and Solid Buy Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, is making waves with its compelling growth story and favorable analyst ratings. As a leader in the diagnostics..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Promising Biotech with 22% Revenue Growth and Strong Buy Ratings

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has emerged as a significant player in the biotechnology sector, capturing investor attention with its innovative enzyme-based technologies and robust financial performance. With a market..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 52% Potential Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leader in the biotechnology sector, is a company that has caught the attention of investors with its focus on rare disease therapies and a..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 9.76% Potential Upside in the Healthcare Sector

Revvity, Inc. (NYSE: RVTY) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $12.12 billion, this U.S.-based company is carving..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Revenue Growth Amid High Valuation

Exact Sciences Corporation (NASDAQ: EXAS) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $19.38 billion, this U.S.-based company is..

The Cigna Group (CI) Stock Analysis: Exploring a 17.2% Potential Upside and Robust Analyst Support

The Cigna Group (NYSE: CI), a stalwart in the healthcare industry, presents a compelling investment opportunity with significant potential upside. Operating in the Healthcare Plans industry, this Connecticut-based company has..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds